1-5 of 5
Daniel Tumas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting DNA repair in chronic lymphocytic leukemia cells with the DNA chain terminator, GS-9219

Cheng-Yu Tsai, Adrian Ray, Daniel Tumas, Michael Keating, Hans Reiser, William Plunkett
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3290.
Published: 01 May 2008
View article
Journal Articles

Intracellular metabolism of GS-9219, a membrane permeable prodrug of 9-(2-phosphonylmethoxyethyl)guanine

Cheng-Yu Tsai, Adrian Ray, Daniel Tumas, Riri Shibata, Hans Reiser, William Plunkett
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3186.
Published: 01 May 2007
View article
Journal Articles

GS-9219: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) with potent activity in hematologic malignancies

Hans Reiser, Adrian Ray, Riri Shibata, Arnold Fridland, William Plunkett, Douglas Thamm, David Vail, William Lee, William Watkins, Gerry Rhodes, Manoj Desai, Daniel Tumas
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3188.
Published: 01 May 2007
View article
Journal Articles

Double-prodrug approach enhances selective lymphatic loading of GS-9219 a candidate for leukemia and lymphoma treatment

Adrian Ray, Daniel Tumas, William Watkins, Gerald Rhodes, Hans Reiser
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3184.
Published: 01 May 2007
View article
Journal Articles

Efficacy and safety profile of GS-9219, a novel guanine nucleotide analog prodrug, for the treatment of lymphoid malignancies using pet dogs with spontaneous non-Hodgkin's lymphoma as a model

David Vail, Douglas Thamm, Daniel Tumas, H Reiser, A Ray, W Watkins, Ilene Kurzman, Robert Jeraj, Susan Plaza, Christine Anderson, MacKenzie Wessel
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5730.
Published: 01 May 2007
View article